Molecular Testing of Pancreatic Cysts

80% of surgeries for pancreatic cysts may not be necessary. The vast majority (~98%) of pancreatic cysts are benign. PancraGEN^® (or PanDNA^®) can provide greater confidence if you are faced with the decision of having surgery or continued follow-up by your doctor. With an accuracy of 90%, molecular testing of pancreatic cysts with PancraGEN^® (or PanDNA^®) is one of the most advanced ways available today to diagnose pancreatic cysts. These specialized tests combine molecular analysis with other clinical test results to assess the likelihood that a pancreatic cyst is cancerous. By looking at the “molecular level” of genes and proteins in the fluid of the cyst, scientists can more confidently assess whether a cyst is malignant or carries the risk for turning into cancer. Your doctor can determine if these tests are appropriate for you.

Learn More About PancraGEN^® and PanDNA^®

>>>>>>>>>>